John L. Brottem
Known title: General CounselCIK: 0001823381
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Hims & Hers news mentioned in broader market context. Recent coverage from Yahoo discusses reasons to retain Hims & Hers stock, which shares the digital health sector with Outset Medical. While the article focuses on a different company, it highlights ongoing investor interest in the broader telehealth and digital medicine space. Outset Medical remains a high-beta stock with significant volatility, as seen in its wide 52-week range.
Transaction History
| ALMR | ▲ Buy | Grant | 29,000 | $0 | 9/14/2026 | View on chart |
| OM | ▼ Sell | Open Market | 2,632 | $12K | 8/17/2026 | View on chart |
| OM | ▲ Buy | Grant | 59,830 | $0 | 6/26/2026 | View on chart |
| OM | ▼ Sell | Open Market | 2,638 | $10K | 5/15/2026 | View on chart |
| OM | ▼ Sell | Open Market | 2,842 | $10K | 2/17/2026 | View on chart |
| OM | ▼ Sell | Open Market | 1,180 | $6K | 1/21/2026 | View on chart |
| OM | ▼ Sell | Open Market | 9,314 | $48K | 1/20/2026 | View on chart |
| OM | ▼ Sell | Open Market | 224 | $956 | 1/7/2026 | View on chart |
| OM | ▼ Sell | Open Market | 388 | $2K | 11/17/2025 | View on chart |
| OM | ▼ Sell | Open Market | 383 | $5K | 8/15/2025 | View on chart |
| OM | ▲ Buy | Grant | 35,993 | $0 | 6/10/2025 | View on chart |
| OM | ▼ Sell | Open Market | 396 | $7K | 5/15/2025 | View on chart |
| OM | ▼ Sell | Open Market | 6,145 | $6K | 2/18/2025 | View on chart |
| OM | ▼ Sell | Open Market | 777 | $622 | 1/21/2025 | View on chart |
| OM | ▼ Sell | Open Market | 29,474 | $24K | 1/21/2025 | View on chart |
| OM | ▼ Sell | Open Market | 2,679 | $2K | 1/21/2025 | View on chart |
| OM | ▲ Buy | Grant | 9,090 | $0 | 1/17/2025 | View on chart |
| OM | ▼ Sell | Open Market | 20,492 | $17K | 1/13/2025 | View on chart |
| OM | ▼ Sell | Open Market | 1,572 | $2K | 1/7/2025 | View on chart |
| OM | ▼ Sell | Open Market | 3,203 | $3K | 11/15/2024 | View on chart |
| OM | ▼ Sell | Open Market | 3,011 | $3K | 8/15/2024 | View on chart |
| OM | ▼ Sell | Open Market | 10,569 | $51K | 6/12/2024 | View on chart |
| OM | ▼ Sell | Open Market | 2,972 | $10K | 5/16/2024 | View on chart |
| OM | ▼ Sell | Open Market | 3,341 | $12K | 2/15/2024 | View on chart |
| OM | ▼ Sell | Open Market | 1,480 | $6K | 1/16/2024 | View on chart |
| OM | ▲ Buy | Grant | 96,000 | $0 | 1/12/2024 | View on chart |
| OM | ▲ Buy | Grant | 100,000 | $0 | 1/12/2024 | View on chart |
| OM | ▲ Buy | Grant | 5,060 | $0 | 1/12/2024 | View on chart |
| OM | ▼ Sell | Open Market | 7,344 | $40K | 1/8/2024 | View on chart |
| OM | ▼ Sell | Open Market | 1,431 | $7K | 11/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,364 | $21K | 8/16/2023 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,415 | $13K | 7/19/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,415 | $28K | 7/19/2023 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,414 | $13K | 6/20/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,414 | $31K | 6/20/2023 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,415 | $13K | 5/17/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,415 | $28K | 5/17/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,317 | $26K | 5/17/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,335 | $27K | 5/16/2023 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,414 | $13K | 5/3/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,414 | $28K | 5/3/2023 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,415 | $13K | 3/20/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,415 | $29K | 3/20/2023 | View on chart |
| OM | ▼ Sell | Open Market | 2,715 | $57K | 3/20/2023 | View on chart |
| OM | ▲ Buy | Option Exercise | 2,265 | $21K | 2/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 2,265 | $54K | 2/16/2023 | View on chart |
| OM | ▲ Buy | Option Exercise | 2,829 | $27K | 2/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 2,829 | $68K | 2/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 3,532 | $86K | 2/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 358 | $9K | 2/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 1,000 | $24K | 2/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 4,282 | $120K | 1/27/2023 | View on chart |
| OM | ▲ Buy | Grant | 38,834 | $0 | 1/6/2023 | View on chart |
| OM | ▲ Buy | Grant | 2,184 | $0 | 1/6/2023 | View on chart |
| OM | ▲ Buy | Option Exercise | 12,761 | $121K | 11/30/2022 | View on chart |
| OM | ▼ Sell | Open Market | 12,761 | $259K | 11/30/2022 | View on chart |
| OM | ▼ Sell | Open Market | 1,918 | $36K | 11/18/2022 | View on chart |
| OM | ▼ Sell | Open Market | 352 | $7K | 11/16/2022 | View on chart |
| OM | ▼ Sell | Open Market | 351 | $8K | 8/16/2022 | View on chart |
| OM | ▼ Sell | Open Market | 349 | $9K | 5/17/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,000 | $9K | 4/18/2022 | View on chart |
| OM | ▼ Sell | Open Market | 1,000 | $43K | 4/18/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,415 | $13K | 4/18/2022 | View on chart |
| OM | ▼ Sell | Open Market | 1,415 | $61K | 4/18/2022 | View on chart |
| OM | ▼ Sell | Open Market | 1,400 | $57K | 3/17/2022 | View on chart |
| OM | ▼ Sell | Open Market | 1,392 | $55K | 3/16/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,000 | $9K | 3/15/2022 | View on chart |
| OM | ▼ Sell | Open Market | 1,000 | $39K | 3/15/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 5,586 | $53K | 3/15/2022 | View on chart |
| OM | ▼ Sell | Open Market | 5,586 | $216K | 3/15/2022 | View on chart |
| OM | ▼ Sell | Open Market | 1,003 | $44K | 3/1/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 3,000 | $28K | 2/15/2022 | View on chart |
| OM | ▼ Sell | Open Market | 3,000 | $108K | 2/15/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 7,002 | $66K | 2/15/2022 | View on chart |
| OM | ▼ Sell | Open Market | 7,002 | $251K | 2/15/2022 | View on chart |
| OM | ▲ Buy | Grant | 23,443 | $0 | 1/26/2022 | View on chart |
| OM | ▲ Buy | Grant | 1,319 | $0 | 1/26/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 3,000 | $28K | 1/18/2022 | View on chart |
| OM | ▼ Sell | Open Market | 3,000 | $107K | 1/18/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 7,002 | $66K | 1/18/2022 | View on chart |
| OM | ▼ Sell | Open Market | 7,002 | $249K | 1/18/2022 | View on chart |
| OM | ▼ Sell | Open Market | 2,500 | $118K | 1/3/2022 | View on chart |
| OM | ▲ Buy | Option Exercise | 3,500 | $33K | 12/1/2021 | View on chart |
| OM | ▼ Sell | Open Market | 3,500 | $168K | 12/1/2021 | View on chart |
| OM | ▲ Buy | Option Exercise | 3,500 | $33K | 11/15/2021 | View on chart |
| OM | ▼ Sell | Open Market | 3,500 | $180K | 11/15/2021 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,445 | $14K | 11/15/2021 | View on chart |
| OM | ▼ Sell | Open Market | 1,445 | $74K | 11/15/2021 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,445 | $14K | 10/19/2021 | View on chart |
| OM | ▼ Sell | Open Market | 1,445 | $72K | 10/19/2021 | View on chart |
| OM | ▲ Buy | Option Exercise | 3,500 | $33K | 10/15/2021 | View on chart |
| OM | ▼ Sell | Open Market | 3,500 | $172K | 10/15/2021 | View on chart |
| OM | ▲ Buy | Option Exercise | 3,500 | $33K | 9/15/2021 | View on chart |
| OM | ▼ Sell | Open Market | 3,500 | $176K | 9/15/2021 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,445 | $14K | 9/15/2021 | View on chart |
| OM | ▼ Sell | Open Market | 1,445 | $73K | 9/15/2021 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,445 | $14K | 9/7/2021 | View on chart |
| OM | ▼ Sell | Open Market | 1,445 | $72K | 9/7/2021 | View on chart |
| OM | ▲ Buy | Option Exercise | 1,445 | $14K | 9/7/2021 | View on chart |
| OM | ▼ Sell | Open Market | 1,445 | $72K | 9/7/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Alamar Biosciences Sets Q3 2026 Earnings Release Date
Alamar Biosciences will report its third‑quarter 2026 financial results on November 3, 2026. The company’s latest article highlights a growing focus on its consumables business, suggesting a potential shift in revenue streams. Investors may watch the earnings release for updates on this strategy.
Alamar Biosciences Sets Q3 2026 Earnings Release Date. Alamar Biosciences will report its third‑quarter 2026 financial results on November 3, 2026. The company’s latest article highlights a growing focus on its consumables business, suggesting a potential shift in revenue streams. Investors may watch the earnings release for updates on this strategy.